In the last trading session, 116.35 million NKGen Biotech Inc (NASDAQ:NKGN) shares changed hands as the company’s beta touched 0.47. With the company’s per share price at $0.57 changed hands at $0.12 or 27.12% during last session, the market valuation stood at $25.60M. NKGN’s last price was a discount, traded about -612.28% off its 52-week high of $4.06. The share price had its 52-week low at $0.20, which suggests the last value was 64.91% up since then.

NKGen Biotech Inc (NASDAQ:NKGN) trade information

Instantly NKGN was in green as seen at the end of in last trading. With action -25.93%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -13.08%, with the 5-day performance at -25.93% in the red. However, in the 30-day time frame, NKGen Biotech Inc (NASDAQ:NKGN) is 12.08% up.

NKGen Biotech Inc (NASDAQ:NKGN)’s Major holders

Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and Fidelity Extended Market Index Fund. With 174.0 shares estimated at $99093.0 under it, the former controlled 0.39% of total outstanding shares. On the other hand, Fidelity Extended Market Index Fund held about 0.15% of the shares, roughly 66.71 shares worth around $37993.0.